中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
29期
39-41
,共3页
改良微创血肿抽吸术%脑出血%临床研究
改良微創血腫抽吸術%腦齣血%臨床研究
개량미창혈종추흡술%뇌출혈%림상연구
Improved minimally invasive hematoma aspiration%Cerebral hemorrhage%Clinical study
目的：探讨改良微创血肿抽吸术治疗脑出血的临床效果。方法该研究整群选取了2011年1月—2015年2月该院收治的202例脑出血患者作为研究对象。均分为治疗组和对照组，各101例，对照组采用临床常规微创血肿抽吸术，治疗组采用该院改良的微创血肿抽吸术进行治疗，对比各自疗效情况。结果治疗组首次抽吸量为14.3 mL， barthel评分为89.4分；对照疗组首次抽吸量为26.7 mL，barthel评分为65.2分。比较发现治疗组在预后结果方面显著优于对照组患者，差异有统计学意义（P<0.01）。治疗组再次出血例数为12例，死亡例数为5例；对照组再次出血例数为31例，死亡例数为19例。比较发现治疗组显著优于对照组患者，差异有统计学意义（P<0.01）。结论改良微创血肿抽吸术是一种有效治疗脑出血的手术方案。该方法治疗效果显著，值得广泛推广和深入研究。
目的：探討改良微創血腫抽吸術治療腦齣血的臨床效果。方法該研究整群選取瞭2011年1月—2015年2月該院收治的202例腦齣血患者作為研究對象。均分為治療組和對照組，各101例，對照組採用臨床常規微創血腫抽吸術，治療組採用該院改良的微創血腫抽吸術進行治療，對比各自療效情況。結果治療組首次抽吸量為14.3 mL， barthel評分為89.4分；對照療組首次抽吸量為26.7 mL，barthel評分為65.2分。比較髮現治療組在預後結果方麵顯著優于對照組患者，差異有統計學意義（P<0.01）。治療組再次齣血例數為12例，死亡例數為5例；對照組再次齣血例數為31例，死亡例數為19例。比較髮現治療組顯著優于對照組患者，差異有統計學意義（P<0.01）。結論改良微創血腫抽吸術是一種有效治療腦齣血的手術方案。該方法治療效果顯著，值得廣汎推廣和深入研究。
목적：탐토개량미창혈종추흡술치료뇌출혈적림상효과。방법해연구정군선취료2011년1월—2015년2월해원수치적202례뇌출혈환자작위연구대상。균분위치료조화대조조，각101례，대조조채용림상상규미창혈종추흡술，치료조채용해원개량적미창혈종추흡술진행치료，대비각자료효정황。결과치료조수차추흡량위14.3 mL， barthel평분위89.4분；대조료조수차추흡량위26.7 mL，barthel평분위65.2분。비교발현치료조재예후결과방면현저우우대조조환자，차이유통계학의의（P<0.01）。치료조재차출혈례수위12례，사망례수위5례；대조조재차출혈례수위31례，사망례수위19례。비교발현치료조현저우우대조조환자，차이유통계학의의（P<0.01）。결론개량미창혈종추흡술시일충유효치료뇌출혈적수술방안。해방법치료효과현저，치득엄범추엄화심입연구。
Objective To investigate the clinical effect of improved minimally invasive hematoma aspiration in the treatment of cerebral hemorrhage. Methods 202 cases with cerebral hemorrhage admitted in our hospital from January 2011 to Febru-ary 2015 were selected as the subjects and equally divided into the treatment group and the control group with 101 cases in each. Patients in the control group were given the clinical conventional minimally invasive hematoma aspiration, and those in the treatment group were treated by minimally invasive hematoma aspiration improved by our hospital. And the efficacy was compared between the two groups. Results The first aspiration volume was 14.3mL in the treatment group, and 26.7mL in the control group, the Barthel score was 89.4 points in the treatment group, and that was 65.2 points in the control group. The prognosis of the treatment group was much better than that of the control group with statistically significant difference, P<0.01. In the treatment group, 12 cases had rebleeding, 5 cases died, in the control group, 31 cases had rebleeding, 19 cases died, the difference between the two groups was statistically significant(P<0.01). Conclusion Improved minimally in-vasive hematoma aspiration is an effective surgical treatment for cerebral hemorrhage with significant effect, so it is worthy of extensive promotion and in-depth study.
